In the global epidemic outbreak background, ventilator is the new crown pneumonia patients "life-saving machine", but due to the number of patients is really huge, resulting in a global shortage of ventilators in the 10 million units or so. Therefore, there are many people seize this business opportunity, relying on the ventilator to become rich.
Myriad Medical is the largest manufacturer of respiratory machines in China, the company's real controller Xu Hang's wealth in the last two months increased by 26% to 19.6 billion, an average daily increase of 327 million yuan, while the personal wealth of 95 billion yuan, becoming the fastest-growing wealth in the Hurun Global Top 100 entrepreneurs. To know that Tencent is only claimed to earn 700 million dollars a day, and Xu Hang's personal growth rate has caught up with half of Tencent.
Some data show that China's exports of invasive ventilators, 60% from the Myriad Medical, in order to cater to the huge demand in the international market, the enterprise production capacity has been expanded by nearly 5 times, but is still in short supply. By the impact of this epidemic, the share price of Myriad Medical has risen from 180.33 yuan / share to 264.72 yuan / share, a single share rose nearly 46.8%, to be counted from its just landed on the Growth Enterprise Market, Myriad Medical's rise reached 442.54%, the market value of more than 300 billion yuan.
In the case of extreme shortages of respiratory machines, there are many cross-border "players". For example, General Motors is working with medical device maker Ventec to produce ventilators at GM's parts plant in Indiana. Ferrari and its parent company are also in talks with Siare Engineering, Italy's largest producer of ventilators, to help the latter with production. Dyson has also been asked by the government to respond immediately to this challenge by providing skills and expertise in all aspects of design, testing, production and transportation.
But there is a certain amount of technology involved in producing a medical device such as a ventilator, and the first challenge facing these crossover companies is technological breakthroughs. The production of a ventilator may take more than 40 days, the assembly of the ventilator also requires trained staff, to achieve mass production in a short period of time, these "cross-border" enterprises also need to face the transformation of the production line, technical barriers, supply of parts and quality inspection and approval of a number of difficult issues, which is why these enterprises across the border at the same time also need to The reason for this is that these companies have to seek cooperation with professional manufacturers.
It is worth mentioning that Myriad Medical has donated a total of more than 33 million yuan of medical equipment to Hubei's sentinel treatment medical institutions, and delivered more than 80,000 units of medical equipment nationwide in an emergency, making a great contribution to the epidemic. 2019, Myriad Medical applied for 884 patents, 249 were authorized; as of the end of 2019*** applied for 4,873 patents, and 2,130 effective patents, which can be said to be a good example of how the company has been able to achieve its goals. 2130 effective patents, which can be said to be a very strong enterprise in scientific research.
Now the overseas epidemic has not ushered in the inflection point, will continue for a long time to save, which means that the growth momentum of Myriad Medical will continue for a long time.
Jie Mobile
Finance and Economy Jie Mobile Dialog